Blog

Spine Surgeon Returns to Competitive Sports, Completes a Triathlon Just 8 Months After Successful Motion-Preserving Spine Surgery

PALM BEACH, FL / ACCESS Newswire / July 7, 2025 / When Dr. Scott Adelman, a nationally recognized leader in endoscopic spine surgery and interventional pain management, began experiencing debilitating low back pain, he understood better than most the complexities and limitations of traditional surgical options. For years, he pursued conservative treatments-physical therapy, spinal injections, and careful lifestyle modifications-but the pain continued to escalate, eventually preventing him from enjoying the activities that once defined his active lifestyle. Competitive snow skiing, triathlons, and fly fishing in the mountains near his Park City, Utah home had all become nearly impossible.

At 62, with his quality of life rapidly declining, Dr. Adelman consulted with several spine specialists. The consensus was a lumbar fusion-a common solution, but one that would restrict mobility and potentially curtail his ability to remain active. For a surgeon who had built his career advocating for minimally invasive, motion-preserving solutions, this was not acceptable.

Determined to explore every option, Dr. Adelman turned to Dr. Jason M. Cuéllar, a fellowship-trained orthopedic spine surgeon known for his expertise in advanced motion-preserving spinal procedures. Practicing in Palm Beach, Jupiter and Miami, Florida, Dr. Cuéllar has become a leader in artificial disc replacement and innovative alternatives to fusion.

Together, Dr. Adelman and Dr. Cuéllar developed a tailored treatment plan focused on preserving motion and function. For Dr. Adelman, the goal was not just pain relief, but the restoration of a life filled with movement, performance, and passion. In October 2024, Dr. Cuéllar performed a three-level lumbar artificial disc replacement (ADR) using the ProDisc system. The procedure involved disc arthroplasty at the L3-4, L4-5, and L5-S1 levels. Conducted through a standard anterior retroperitoneal approach, Dr. Cuéllar was able to completely remove the damaged discs and precisely implant the artificial discs at all three levels, preserving Dr. Adelman’s spinal motion and improving his quality of life.

“Scott’s case was complex, but he was an excellent candidate for lumbar disc replacement,” said Dr. Cuéllar. “Given his active lifestyle, preserved facet joints, and desire to avoid fusion, multilevel ADR offered the best opportunity to relieve his pain while preserving motion across the lumbar spine. I am thrilled with his recovery and his return to high-level activities-including a triathlon at 8 months post-op!”

Dr. Adelman’s surgical outcome has been exceptional. By four months postoperatively, he was back on the slopes skiing black diamond runs in Park City. Eight months after surgery, Adelman completed a triathlon with no back pain. “It was discouraging to think that most of my lumbar spine would be fused,” said Dr. Adelman. “Recovery would have taken at least six months, and I would have lost mobility at those levels. Dr. Cuéllar’s expertise in multilevel total disc replacement prevented me from that outcome. I am not only grateful for the surgical result but for the ability to resume the activities I love.”

Dr. Adelman’s career as a pioneer in endoscopic spine surgery has been unique. Without following the traditional U.S. spine surgery training pathway, he built an international reputation through more than two decades of performing endoscopic spinal decompressions, helping thousands of patients avoid open surgery. His nontraditional background and innovative approach to spinal care made him an early advocate for minimally invasive techniques that prioritize motion preservation-values that aligned closely with Dr. Cuéllar’s expertise in artificial disc replacement.

Dr. Cuéllar, founder at Cuéllar Spine and a member of the national ADR Spine Top Doctors in Arthroplasty Program, continues to build a reputation for successfully treating complex lumbar and cervical disc disease with motion-preserving surgical solutions. His growing referral base includes not only patients but also physicians and spine care specialists seeking second opinions and alternatives to spinal fusion.

For Dr. Adelman, the choice to pursue total disc replacement reflects both professional insight and personal experience. His story underscores the expanding role of lumbar TDR as a preferred option for appropriately selected patients with multi-level degenerative disc disease.

About Dr. Jason M. Cuéllar

Jason M. Cuéllar, M.D., Ph.D., is a fellowship-trained orthopedic spine surgeon with a practice focused exclusively on motion preservation and minimally invasive spine surgery. Based in Palm Beach, Jupiter and Miami, Florida, Dr. Cuéllar is a recognized leader in total disc replacement (TDR) for both the cervical and lumbar spine. As one of the earliest inductees into the ADR Spine Top Doctors in Arthroplasty Program, he is frequently sought out by patients nationwide seeking alternatives to spinal fusion. Dr. Cuéllar’s academic contributions include over three dozen peer-reviewed publications in the field of spine surgery, and he continues to participate in clinical research advancing the science of motion preservation. For more information, visit www.CuellarSpine.com.

About Dr. Scott Adelman

Dr. Scott Adelman is a board-certified physiatrist and a national leader in interventional spine care and endoscopic spine surgery. Based in Park City, Utah, Dr. Adelman has spent over two decades pioneering minimally invasive techniques that help patients avoid traditional open spine surgeries. With a background in physical medicine and rehabilitation, he has developed specialized expertise in outpatient endoscopic procedures, treating thousands of patients with chronic back and neck pain. Dr. Adelman continues to lecture nationally and internationally on advanced spine care techniques, with a professional focus on helping patients preserve spinal function and avoid unnecessary fusion surgeries. For more information, visit www.thesmartclinic.com.

About the ADR Spine Top Doctors in Arthroplasty Program

The ADR Spine Top Doctors in Arthroplasty Program recognizes and supports the nation’s leading surgeons in motion preservation spine surgery. Founded by Dr. Todd H. Lanman, the program highlights physicians who meet rigorous standards for clinical excellence, surgical volume, and patient outcomes in total disc replacement (TDR) and other motion-preserving procedures. Program members are selected for their commitment to innovation, patient-centered care, and their expertise in restoring spinal motion for individuals suffering from degenerative spine conditions. For more information, visit www.adrspine.com.

Contact:

Brandi Kamenar
Brandi Kamenar Brand Management
310-734-6180

SOURCE: Cuéllar Spine

View the original press release on ACCESS Newswire

REDMOND, WA / ACCESS Newswire / July 7, 2025 / CoreStack, the global leader in AI-powered next-generation cloud governance, today announced the launch of CoreStack Graphion™, a breakthrough Cloud-Native Application Protection Platform (CNAPP) engineered for today’s hyper-connected, high-velocity software ecosystems. With the escalating threat landscape and mounting compliance mandates, Graphion redefines security by fusing Agentic AI, deep SBOM + IBOM intelligence, and real-time graph-based threat modeling into a single, unified platform.

“Security can’t wait – and with Graphion, it doesn’t have to,” said Ezhilarasan Natarajan, Chief Executive Officer at CoreStack. “We’ve fused intelligence and action to give security leaders what they really need: clarity, prioritization, and control. Graphion doesn’t just show what’s vulnerable – it shows what matters.”

This innovation is further accelerated by CoreStack’s recent acquisition of Karthik Consulting (KC), a federal cybersecurity and DevSecOps leader. By combining KC’s deep expertise in secure federal systems, with CoreStack’s AI-powered governance platform, the two companies are unifying their strengths to deliver an integrated CNAPP offering. This strategic alignment amplifies CoreStack’s platform capabilities with federal-grade security, ensuring both enterprise and government customers benefit from a secure, scalable, and compliance-ready solution.

Built for the New Reality of Cloud Risk

Today’s cloud-native applications are assembled rapidly from a vast and volatile software supply chain, then deployed into ephemeral, containerized infrastructure. This agility introduces new risks at every turn – from unscanned code to misconfigured assets and overlooked policy drift.

Graphion addresses these risks head-on, offering:

• A living graph of application, infrastructure, security posture and its attack path.

• Unified visibility through integrated SBOM (Software Bill of Materials) and IBOM (Infrastructure Bill of Materials).

• Intelligent prioritization based on business impact and real-world exploitability.

Agentic AI That Understands Context and Drives Action

At the core of Graphion is CoreStack’s Large Cloud Governance Model™ (LCGM) – an Agentic AI engine that goes beyond classification to deliver targeted, autonomous responses. It continuously:

• Understands application context and business criticality.

• Flags vulnerabilities based on real-world risk propagation.

• Recommends and explains precise remediation paths.

Designed for Real Security, Not Just Policy

Graphion brings together visibility, enforcement, and validation to deliver on the promise of Zero Trust. It:

• Validates every change, deployment, and connection against policy.

• Automates continuous ATO (cATO) with built-in compliance artifacts.

• Tracks posture across time and environments for true auditability.

By embedding controls directly into the DevSecOps pipeline, Graphion replaces fragmented reviews with continuous, automated assurance.

Built for the Enterprise. Ready for the Mission.

Graphion integrates seamlessly with leading cloud platforms (Azure, AWS, GCP, Oracle) and supports critical frameworks such as NIST, FedRAMP, and EO 14028. With modular deployment, out-of-the-box integrations, and a graph data model built for extensibility, it empowers enterprises to govern their software supply chain – securely, autonomously, and at scale.

Join the Preview

Select enterprise and federal partners are now onboarding to the Graphion early access program, gaining firsthand access to its powerful graph-based security engine and AI-driven insights.

To request access to the preview, visit https://www.corestack.io/graphion

SOURCE: CoreStack Inc.

View the original press release on ACCESS Newswire

Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in Plasmacure B.V

MISSOULA, MT / ACCESS Newswire / July 7, 2025 / Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing. Venture Medical is leading a €6 million Series A round alongside Coöperatie VGZ, Noaber, Stichting Triade, and existing investors EIC Fund and OostNL. In addition to the direct investment, Venture Medical is also committing over $10 million to support PLASOMA’s regulatory approval, reimbursement efforts, and U.S. market expansion.

This partnership underscores Venture Medical’s ongoing mission to empower providers to deliver healing without boundaries by introducing disruptive technologies that improve patient outcomes and expand access to state-of-the-art care.

“As a leading cause of amputations, sepsis, and many other severe complications, chronic wounds impact the lives of millions of patients while presenting a growing burden to our healthcare system,” said John Schroeder, CEO of Venture Medical. “We see PLASOMA as a transformative technology that redefines what’s possible in wound healing. By investing in Plasmacure and supporting its U.S. rollout, we are enabling clinicians to offer next-generation care that is both innovative and accessible.”

PLASOMA is a novel wound healing system delivering cold plasma through an intuitively designed pulser and specialized applicator, safely generating plasma from room air directly on the wound surface. Cold plasma has demonstrated powerful antimicrobial effects, while simultaneously promoting tissue regeneration through a variety of other mechanisms. In a recent clinical trial, PLASOMA therapy showed 2.5 times more wound closure than current standards of care.

For Venture Medical, the investment is part of a broader commitment to helping healthcare providers access groundbreaking tools across biologics, diagnostics, durable medical equipment, and digital solutions. PLASOMA aligns directly with this vision by offering a scalable, scientifically backed option for treating diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other hard-to-heal wounds.

“As our population ages and chronic conditions become more prevalent, the need for effective wound healing solutions grows more urgent,” added Schroeder. “With PLASOMA, we’re not just treating wounds, we’re restoring access, independence, and dignity to patients who’ve been living without hope.”

The funding will accelerate Plasmacure’s global scale-up while laying the groundwork for U.S. FDA clearance, payer access, and national distribution through Venture Medical’s extensive provider network.

“We are deeply motivated by the needs of the millions living with hard-to-heal wounds,” said Bjorn Sprengers, CEO of Plasmacure. “With this investment and our new strategic partners, we are in a strong position to bring PLASOMA to more patients worldwide.”

About Venture Medical, LLC
Venture Medical is a U.S.-based healthcare services company specializing in advanced wound care. As a master distributor and digital solutions partner, Venture Medical equips clinicians with breakthrough biologics, diagnostics, and capital equipment to improve patient outcomes across care settings. Learn more at www.venturemedical1.com.

About Plasmacure B.V.
Founded in 2014 in the Netherlands, Plasmacure is the developer of PLASOMA, a cold plasma therapy designed to accelerate healing in chronic wounds. The company aims to revolutionize wound care through safe, effective, and scalable technology. Visit www.plasmacure.nl to learn more.

SOURCE: Venture Medical LLC

View the original press release on ACCESS Newswire

BEIJING, CHINA AND MADRID, SPAIN / ACCESS Newswire / July 7, 2025 / Hygreen Energy , a global electrolyzer manufacturer and hydrogen technology leader, has entered a frame agreement with Robert Bosch GmbH to integrate Bosch’s Hybrion PEM electrolysis stacks into Hygreen’s large-scale PEM hydrogen system offerings. Through this multi-year partnership, Hygreen will bring a fully commercially ready, large-scale hydrogen production system to worldwide markets using Bosch Hybrion PEM stacks.

As a result of the agreement with Bosch, Hygreen will strategically deliver PEM projects over 1 MW size using Bosch’s Hybrion PEM stacks. The result is an expanded product portfolio with broader appeal to hydrogen project developers, EPCs, and industrial customers seeking flexibility, scalability, and speed to market, with two globally trusted brand names.

“We are proud to partner with Bosch, whose Hybrion PEM stack performance, high manufacturing standards, and scale capacity will help us serve a growing number of green hydrogen projects globally,” said Benny Wang, CEO of Hygreen Energy. “Through hundreds of successful deployments around the world, Hygreen has shown its capabilities already and we are looking forward to start a new and promising chapter with Bosch.”

Bosch’s Hybrion PEM stack delivers up to 1.25 MW of input power, up to 34 bar output pressure, and producing up to 23 kg of hydrogen per hour, while maintaining high efficiency and seamless integration into containerized and skid-mounted designs. Hygreen Energy will standardize this stack into its 1.25 MW and 5 MW hydrogen systems, enabling rapid deployment in projects ranging from energy storage to industrial decarbonization.

While Bosch brings manufacturing excellence, and high PEM stack quality standards, it is Hygreen’s system-level expertise that unlocks real-world performance. As a company that has delivered more than 300 hydrogen projects across five continents – from desert environments to polar research bases – Hygreen Energy’s in-market experience validates its ability to design, deliver, and support complete electrolyzer systems that project developers have come to trust.

“We are excited to bring large-scale hydrogen production systems to market with our partner Hygreen Energy.Scalability and manufacturing excellence are core to Bosch’s DNA and key to the future of a hydrogen economy. That’s how the Hybrion PEM electrolysis stack by Bosch contributes to a demand-oriented and clean hydrogen production with highest efficiency.” – Matthias Ziebell, Senior Vice President for Sales, Energy Markets, and Business Development, Robert Bosch GmbH.

About Hygreen Energy

Hygreen Energy is a world leading electrolyzer manufacturer that offers comprehensive solutions to green hydrogen production. Specializing in Alkaline, PEM, and AEM technologies, Hygreen electrolyzers are rigorously tested, robustly built, and extensively proven with in-field usage by customers worldwide. Backed by over 18 years of experience and over 300 electrolyzer projects delivered, Hygreen Energy’s engineers are some of the world’s most experienced professionals when supporting EPCs and hydrogen project developers. By transforming the electrolyzer industry with unparalleled efficiency, safety, cost, and durability, Hygreen Energy is enabling the world’s clean energy transition by supporting the growth of green hydrogen across many industries. Say hello to a greener future with Hygreen Energy, and visit us at www.hygreenenergy.com .

Source: Hygreen Energy

Hygreen Energy Media Inquiries:

Ethan Hugh | Global Marketing Director | ehugh@hygreenenergy.com

SOURCE: Hygreen Energy

View the original press release on ACCESS Newswire

Leading U.S. health and wealth distribution company excels in employee satisfaction and workplace culture

CLEARWATER, FLA. / ACCESS Newswire / July 7, 2025 / AmeriLife Group, LLC (“AmeriLife”), a national organization that develops, markets, and distributes life and health insurance, annuities, and retirement planning solutions, is proud to announce its certification as a Great Place to Work®. This prestigious recognition is based entirely on the feedback of current employees, with 83% of AmeriLife team members reporting that it is a great place to work, 26 points higher than the average employee satisfaction at U.S. companies.

“We are thrilled to be recognized as a Great Place to Work-Certified™ company,” said Scott R. Perry, chairman and CEO of AmeriLife. “At AmeriLife, we believe that our dedicated and talented team drives our success. We are committed to fostering a culture of trust, respect, and innovation, and this recognition is a testament to our ongoing efforts.”

“At AmeriLife, we are deeply committed to making our company an employer of choice by continually evolving our benefits and focusing on strengthening our company culture,” added Kiersten Burstiner, Chief Human Resources Officer of AmeriLife. “Our approach is centered around ensuring that every team member feels supported, valued, and connected to an environment where collaboration and growth are at the forefront of each interaction.”

According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified Great Workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work. They are twice as likely to be paid fairly, earn a fair share of the company’s profits, and have a fair chance of promotion.

“Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,” says Sarah Lewis-Kulin, Vice President of Global Recognition at Great Place To Work. “By successfully earning this recognition, it is evident that AmeriLife stands out as one of the top companies to work for, providing a great workplace environment for its employees.”

Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention, and increased innovation.

About AmeriLife
AmeriLife’s strength lies in its mission: to provide insurance and retirement solutions that help people live longer, healthier lives. AmeriLife develops, markets, and distributes life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a national distribution network of over 300,000 agents, financial professionals, and more than 160 marketing organizations and insurance agencies. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn.

About Great Place to Work Certification™
Great Place To Work® Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience, specifically, how consistently they experience a high-trust workplace. Great Place To Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.

About Great Place To Work®
As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List. Learn more at greatplacetowork.com and follow Great Place To Work on LinkedIn, Twitter, Facebook, and Instagram.

SOURCE: AmeriLife

Related Images

View the original press release on ACCESS Newswire

STONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share, and that the Company is therefore in compliance with the Nasdaq Capital Market’s listing requirements. Nasdaq also notified the Company in the Compliance Notice that the hearing before the Nasdaq Hearings Panel previously scheduled to take place on July 15, 2025, has been cancelled, and the Company’s securities will continue to be listed and traded on The Nasdaq Capital Market.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company with over 20 years of experience in developing and commercializing polymerase chain reaction (PCR)-based applications for DNA production. Through its majority-owned subsidiary, LineaRx Inc., the Company is commercializing its LineaDNA and LineaIVT platforms to enable the manufacture of next-generation nucleic acid-based therapies.

Visit adnas.com for more information. Follow us on X and LinkedIn.

Forward-Looking Statements

The statements made by Applied DNA Sciences in this press release may be “forward-looking” in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. These forward-looking statements are based largely on the Company’s expectations and projections about future events and future trends affecting our business and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Actual results could differ materially from those projected due to the Company’s history of net losses, limited financial resources, substantial doubt regarding its ability to continue as a going concern, unknown future ability to continue its listing on the Nasdaq Capital Market, unknown future demand for its biotherapeutics products and services, the unknown amount of revenues and profits that will result from our LineaDNA and/or LineaIVT platforms, the fact that there has never been clinical trial material and/or a commercial drug product produced utilizing the LineaDNA and/or LineaIVT platforms, as well as various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including its Annual Report on Form 10-K filed on December 17, 2024, its Quarterly Reports on Form 10-Q filed on February 13, 2025, and May 15, 2025, and other reports it files with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.

Applied DNA Sciences Contact:

Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

Web: https://investors.adnas.com

SOURCE: Applied DNA Sciences, Inc.

View the original press release on ACCESS Newswire

Trusted Coach Steps Into Leadership Role as Company Continues to Scale Internationally

SCOTTSDALE, ARIZONA / ACCESS Newswire / July 7, 2025 / Phone Ninjas, the automotive industry’s leader in dealership-specific coaching and training, proudly announces the promotion of Laura Taylor-Artl to Director of Account Services. Laura’s new role reflects her continued leadership in client operations, process execution, and team development across a rapidly expanding dealer portfolio.

“Laura is the person you want talking with customers,” said Chris Vitale, COO at Phone Ninjas. “She’s detailed, dependable, and dealer-focused. As we scale, her leadership will ensure that every account receives the attention and strategy it deserves.”

Laura has been instrumental in building Phone Ninjas’ account service structure, helping onboard new clients, managing complex group rollouts, and ensuring coaching plans stay aligned with dealership goals. As Director, she will lead the account services team, standardize internal systems, and serve as a senior contact for high-level partners.

“What excites me is seeing dealership teams evolve,” said Laura. “When they decide to focus on the customer communications and start taking control of the conversation, you can feel the shift. It’s an impressive culture shift, and I love being a part of it.”

Laura’s promotion comes as Phone Ninjas continues its momentum across variable and fixed operations departments, helping clients improve communication performance where it matters most: at the frontline.

About Phone Ninjas

Founded in 2010, Phone Ninjas helps businesses master all client-facing communications with one goal in mind: better conversations that lead to better results. Through expertly designed ongoing coaching and training programs that support the sales, service, and parts departments, Phone Ninjas helps dealers turn all client interactions into appointments that show and buy.

SOURCE: Phone Ninjas

View the original press release on ACCESS Newswire

GoodData AI capabilities, including AI Assistant and Smart Search, now available for self-hosted deployment. Keep your data private, compliant, and AI-fuelled.

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / July 7, 2025 / GoodData, the AI-native analytics platform, today announced GoodData AI is now available for self-hosted deployment. Enterprises can now run GoodData AI, including AI Assistant and Smart Search, entirely within their own infrastructure – on-premises or in a private cloud – with zero third-party data exposure.

With this launch, GoodData delivers the full promise of AI-driven analytics while honoring the strict privacy, compliance, and control requirements of modern enterprises. Self-hosting gives organizations total ownership of their analytics workflows, from natural language queries to insight generation, all within their secure perimeter.

“Enterprises shouldn’t have to choose between innovation and control. With self-hosted GoodData AI, we’re giving our customers the best of both worlds – cutting-edge generative analytics, deployed entirely on their terms. This is a major step toward making AI not just powerful, but practical and secure for every organization.”

Roman Stanek, Founder and CEO, GoodData

Enterprise-Grade AI, Fully Private

Self-hosted GoodData AI brings a new level of confidence to enterprises that demand the highest in data security. Key benefits include:

• Enterprise Data Privacy: All interactions with AI, including queries, search, and generated insights, remain entirely within your environment. No external processing. No vendor lock-in.

• Deployment Flexibility: Choose how and where to run your AI-powered analytics. GoodData supports deployment on-premises or in your private cloud, seamlessly integrating with your existing tools and infrastructure.

• Compliance & Control: Align easily with regulatory standards such as GDPR, HIPAA, and others. Organizations maintain complete control over updates, access policies, and model tuning.

AI That Works Where You Work

Self-hosted GoodData AI isn’t just secure – it’s smart, scalable, and built to fit into any modern data ecosystem. From business users to developers, every part of the platform is engineered for seamless, intelligent interaction:

• AI Anywhere: Add natural language analytics anywhere – UI, embedded apps, or workflows – with full white-label support for branded experiences.

• Intelligent Semantic Layer and Ontology: AI that understands your business using governed, domain-aware semantic models that deliver contextually accurate answers.

• Natural Language Insights: Get conversational access to precise answers, visualizations, and next steps, all aligned with your data model.

• AI-Ready Analytics Lake: Built on a unified, high-quality data foundation that supports scalable, real-time AI interactions across all analytics layers.

• Model Context Protocol (MCP) Support: Enables real-time, cross-system context that makes AI relevant. GoodData’s new MCP Server Beta program is now available!

• Developer Tools and APIs: API-first architecture enables developers to embed, automate, and integrate AI into any enterprise workflow or application.

This architecture enables enterprises to bring AI directly into decision-making processes – quickly, intelligently, and securely.

“With the release of GoodData AI for self-hosted deployment, we’re making enterprise analytics more intelligent, accessible, and scalable than ever. These capabilities empower developers and business users alike to interact with governed data through natural language and intuitive search.”

Jan Franek, Senior Product Manager, GoodData

“We’re excited to bring GoodData into our ecosystem of partners, helping us deliver secure, self-hosted AI capabilities for public safety. By enabling agencies to ask questions in plain language and instantly turn data into actionable insights, we’re helping officers work more efficiently, accelerate investigations, and enhance community safety-all within a compliant, cloud environment that ensures full data privacy and control.”

Wendy Gilbert, SVP of Product, Mark43

AI, On Your Terms

With self-hosted GoodData AI, organizations can finally combine the flexibility of open architecture with the intelligence of next-gen analytics, while complying with the strictest security protocols.It’s the latest step in GoodData’s vision to bring trusted, explainable AI to every analytics interaction.

For more information, visit www.gooddata.com.

---

About GoodData

GoodData is the AI-native analytics platform built for speed, scale, and trust, helping companies deliver real-time insights – embedded, branded, and everywhere your users need them.

Founded in 2007, and with offices in both the U.S. and Europe, GoodData serves over 140,000 of the world’s top companies and 3.6 million users, helping them drive meaningful change and maximize the value of their data.

For more information, visit GoodData’s website and follow GoodData onLinkedIn, YouTube, and Medium.

GoodData Contact

press@gooddata.com

©2025, GoodData Corporation. All rights reserved. GoodData and the GoodData logo are registered trademarks of GoodData Corporation in the United States and other jurisdictions. Other names used herein may be trademarks of their respective owners.

SOURCE: GoodData

View the original press release on ACCESS Newswire

The SPAC Market Trends & Sentiment Survey, recently conducted by DealFlow Events at The SPAC Conference

NEW YORK CITY, NY / ACCESS Newswire / July 7, 2025 / A new survey of SPAC market professionals released today reveals a cautiously optimistic outlook for the sector, with expectations for increased IPO activity and improved de-SPAC performance over the next year. The SPAC Market Trends & Sentiment Survey, conducted by DealFlow Events in June 2025 at The SPAC Conference, gathered insights from investment bankers, attorneys, SPAC sponsors, and investors actively involved in the SPAC ecosystem.

“This survey reflects a shift in tone from skepticism to optimism,” said Steven Dresner, Founder of DealFlow Events. “While challenges remain, the SPAC market appears to be regaining its footing with a clearer path forward.”

Key findings of the survey:

Cautious Optimism About Market Health

A majority of respondents described the current state of the SPAC market as “Somewhat Healthy,” indicating a stabilizing environment following a period of volatility. That positive sentiment rises to 84% when “Very Healthy” responses are included.

IPO Activity Poised to Rebound

Over 95% of respondents expect a moderate to significant increase in SPAC IPO activity over the next 12 months, suggesting improving sentiment among market participants.

Biggest Obstacles Still Persistent

Respondents cited public market performance, negative media sentiment, and difficulty securing PIPE financing as the top challenges facing SPACs today.

Performance Expectations Trending Upward

Most survey participants (61%) predict a significant improvement in the performance of de-SPAC transactions compared to the previous year.

High-Conviction Sectors for SPAC Deals

The most attractive sectors identified in the survey were Technology, Healthcare/Life Sciences, AI/Robotics, Energy, and Fintech – highlighting investor appetite for innovation-driven growth.

The full results of the SPAC Market Trends & Sentiment Survey can be found online at the following link: https://dealflowevents.com/resources/

In addition to the annual SPAC Conference, DealFlow Events host other industry-leading events including The Private Credit Sourcing Conference October 20-21 in NYC and The PIPEs Conference November 12-13, in Florida.

Media Contact:

Phillip LoFaso
Managing Director
DealFlow Events
(516) 876-8006
phillip@DealFlowEvents.com

SOURCE: DealFlow Events

View the original press release on ACCESS Newswire